In a patient with elevated bilirubin and cholestatic pruritus, a normal chest radiograph and no lymphadenopathy, what is the recommended diagnostic work‑up and symptomatic treatment?

Diagnostic Work-Up and Management of Cholestatic Pruritus

In a patient with elevated bilirubin and cholestatic pruritus who has a normal chest X-ray and no lymphadenopathy, begin with abdominal ultrasound to differentiate extrahepatic from intrahepatic cholestasis, and treat moderate to severe pruritus with bezafibrate as first-line pharmacological therapy. 1

Initial Diagnostic Approach

Imaging Strategy

• Perform abdominal ultrasound immediately to determine whether bile ducts are dilated, which distinguishes extrahepatic from intrahepatic cholestasis 2

• If bile ducts are dilated and interventional treatment is likely needed: proceed directly to ERCP or transhepatic cholangiography 2

• If bile ducts are dilated but interventional treatment is unlikely: obtain cholangio-MRI instead 2

• If ultrasound shows no bile duct dilation and excludes space-occupying lesions: proceed with work-up for intrahepatic cholestasis 2

Specific Clinical Context Considerations

The patient's demographic and clinical features guide the differential diagnosis 2:

• Middle-aged women: Primary biliary cirrhosis is most likely 2
• Young males with inflammatory bowel disease: Suspect primary sclerosing cholangitis 2
• Elderly patients: Drug-induced cholestatic disease should be the primary consideration 2
• Young patients with risk factors: Consider cholestatic viral hepatitis 2
• Presence of spider nevi, ascites, alcohol history: Points to alcoholic hepatitis 2

Laboratory and Additional Work-Up

• Confirm cholestatic pattern: Alkaline phosphatase and gamma-glutamyltransferase elevations should exceed ALT and AST levels 3

• Assess for complications of prolonged cholestasis: Check for fat-soluble vitamin deficiencies (A, D, E, K) 2, 3

• In sclerosing cholangitis specifically: Exclude relevant bile duct strictures as the cause of progressive pruritus, as these require endoscopic intervention 1

Symptomatic Treatment of Pruritus

First-Line Pharmacological Treatment

Bezafibrate is the recommended first-line pharmacological treatment for moderate to severe cholestatic pruritus 1:

• The FITCH trial demonstrated clear benefit of bezafibrate versus placebo in alleviating moderate to severe itch in PSC and PBC patients 1
• Bezafibrate provides sustained antipruritic effects and has strong additive anticholestatic effects when combined with UDCA 1
• No major side effects were observed during short-term (3 weeks) or long-term (2 years) treatment, though serum creatinine may mildly increase and myalgia has been reported 1

Second-Line Pharmacological Treatment

Rifampicin (150-300 mg daily) is recommended as an alternative pharmacological option for moderate to severe pruritus 1

Non-Pharmacological Measures

Implement these supportive measures for all patients 1:

• Use emollients to prevent skin dryness
• Avoid hot baths or showers
• Apply cooling gels (e.g., menthol gels) to affected skin areas
• Keep nails shortened to minimize excoriation

Treatments NOT Recommended

Cholestyramine is no longer recommended as first-line treatment in sclerosing cholangitis due to limited evidence of effectiveness compared to PBC, and because it impairs absorption of other medications including UDCA 1

Management of Refractory Cases

• For intractable pruritus unresponsive to medical therapy: Plasma perfusion through anionic resin (BR-350) has shown 92% bile acid adsorption efficiency and provides symptomatic relief 4

• If hepatocellular failure or portal hypertension complications develop: Consider liver transplantation 2

Important Caveats

• In sclerosing cholangitis with progressive pruritus: Always exclude treatable bile duct strictures before attributing symptoms solely to the underlying disease, as these strictures require endoscopic balloon dilation or stenting after brushing 1

• Monitor for osteopenia and fat-soluble vitamin deficiencies as complications of prolonged cholestasis that require specific correction 2

• Consider rare paraneoplastic causes: In unexplained cholestasis, investigate for occult malignancies including prostate cancer, particularly if standard work-up is unrevealing 5